LILY CHENG to Middle Aged
This is a "connection" page, showing publications LILY CHENG has written about Middle Aged.
Connection Strength
0.014
-
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma. Leuk Lymphoma. 2024 Dec; 65(12):1789-1800.
Score: 0.014